Anti-Snoring Devices Market - Global Forecast to 2029
商品番号 : SMB-72233
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年1月 |
| ページ数 | 280 |
| 図表数 | 429 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
Global Anti-Snoring Devices Market Size is estimated to be about USD 0.91 Billion in 2024 and estimated to reach about USD 1.45 Billion by the year 2029, at a growth rate of CAGR of 9.8% during the forecasted period.
世界のいびき防止装置市場規模は、2024年に約9億1,000万米ドル、予測期間中のCAGR 9.8%の成長率で、2029年までに約14億5,000万米ドルに達すると推定されています。
The market is projected to expand due to the increasing prevalence of sleep disorders such as sleep apnea, advancements in sleep therapy technologies, and the growing elderly population, which often faces a higher risk of chronic diseases. However, growth may be constrained by the high costs associated with oral sleep appliances and the complexity of referral processes.
睡眠時無呼吸症候群などの睡眠障害の有病率の増加、睡眠治療技術の進歩、慢性疾患のリスクが高まる高齢者人口の増加により、市場は拡大すると予測されています。ただし、口腔睡眠器具に関連する高コストと紹介プロセスの複雑さによって、成長が制限される可能性があります。
Efforts led by government health initiatives and public awareness campaigns addressing sleep disorders are driving market growth further. Moreover, innovations in oral appliance technology and improved comfort features are enhancing patient compliance, encouraging adoption. Despite these positive factors, challenges like expensive devices and complicated diagnostic pathways may slow the growth rate. Nonetheless, the market is set to progress steadily, driven by a stronger focus on sleep health and greater accessibility to advanced treatment solutions.
“The oral appliances segment accounted for the largest share of the market in 2023, by device type.”
The anti-snoring devices market, categorized by device type, includes oral appliances, nasal devices, position control devices, chin straps, and EPAP therapy devices. In 2023, oral appliances held the largest market share, primarily due to the growing popularity of mandibular advancement devices (MADs). This dominance is supported by extensive research demonstrating their superior effectiveness compared to other anti-snoring solutions.
“Home care settings segment dominated the anti-snoring devices market in 2023, based on end user.”
Based on end users, the anti-snoring devices market is segmented into home care settings and hospitals & clinics. The home care settings segment accounted for the largest share of the anti-snoring devices market in 2023. The large share of this segment can be attributed to the increasing patient preference for home sleep testing and the growing number of advanced home sleep care devices available in the market. “Asia Pacific: The fastest-growing region in Anti-snoring devices market.”
The worldwide market for Anti-snoring devices is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Notably, the Asia Pacific region is anticipated to experience the most substantial growth in the forecast period. Due to the high prevalence of symptomatic OSA among middle-aged men and women, the anti-snoring devices market in several Asia Pacific countries is expected to witness high growth during the forecast period.
The large patient pool and population of undiagnosed patients indicate a massive potential for the Asia Pacific anti-snoring devices market. The regional and leading players have collaborated, signed several deals, and expanded their presence. Another major growth driver of this segment in the Anti-snoring devices market is the increasing healthcare expenditure, along with supportive regulatory frameworks. All these factors propel increased growth of the Anti-snoring devices market in the Asia Pacific region.
The break-up of the profile of primary participants in the Anti-snoring devices market:
- By Company Type: Tier 1 – 55%, Tier 2 – 25%, and Tier 3 – 20%
- By Designation: M-level – 30%, D-level – 50%, and Others – 20%
- By Region: North America – 51%, Europe – 21%, Asia Pacific – 18%, Latin America – 6%, and Middle East & Africa- 2%, GCC Countries – 2% (Others-4%)
The key players in this market are are ResMed (US), SomnoMed (Australia), ProSomnus Sleep Technologies (US), and Vivos Therapeutics, Inc. (US), DynaFlex (US), OpenAirway (Canada), Panthera Dental (Canada), Airway Management (US), Apnea Sciences (US), OravanOSA (US), Myerson LLC. (US), Braebon Medical Corporation (Canada), MPowrx Health and Wellness Products (Canada), The Snore Reliever Company, LLC (US), Tomed GmbH (Germany), The Aurum Group (Canada), OSCIMED SA (Switzerland), SICAT GmbH & Co. KG (Germany), Glidewell (US), ApnoMed, Inc. (US), ZQuiet (US), among others.
Research Coverage:
This research report categorizes the Anti-snoring devices market by device type (Mandibular Advancement Devices, Tongue-retaining Devices, Nasal Devices, Position Control Devices, Chin Straps, EPAP Therapy Devices ), by gender (male, female), by age (below 40, between 40 to 60, above 60), by distribution channel(online, retail, hospital), by end user (home care settings, hospitals & clinics), and region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa and GCC Countries). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the Anti-snoring devices market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product & service launches, and recent developments associated with the Anti-snoring devices market. Competitive analysis of upcoming startups in the Anti-snoring devices market ecosystem is covered in this report.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall Anti-snoring devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (rising incidence of OSA and snoring population, and increased sleep devices technologies ) opportunities (Growth opportunities in emerging economies), restraints (high cost of devices, Unfavorable reimbursement scenario), and challenges (changing regulatory landscape) influencing the growth of the Anti-snoring devices market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the Anti-snoring devices market.
- Market Development: Comprehensive information about lucrative markets – the report analyses the Anti-snoring devices market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Anti-snoring devices market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like ResMed (US), SomnoMed (Australia), ProSomnus Sleep Technologies (US), and Vivos Therapeutics, Inc. (US), DynaFlex (US).
Table of Contents
1 INTRODUCTION 30
1.1 STUDY OBJECTIVES 30
1.2 MARKET DEFINITION 30
1.3 MARKET SCOPE 31
1.3.1 MARKET SEGMENTATION 31
1.3.2 INCLUSIONS & EXCLUSIONS 32
1.3.3 YEARS CONSIDERED 33
1.3.4 CURRENCY CONSIDERED 33
1.4 STAKEHOLDERS 33
1.5 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key industry insights 39
2.1.2.3 Key data from primary sources 39
2.1.2.4 Breakdown of primary interviews 40
2.2 MARKET SIZE ESTIMATION 40
2.2.1 BOTTOM-UP APPROACH 41
2.2.1.1 Approach 1: Company revenue estimation approach 41
2.2.1.2 Approach 2: Presentations of companies and primary interviews 42
2.2.1.3 Approach 3: Patient-based approach 42
2.2.1.4 Growth forecast 43
2.2.1.5 CAGR projections 43
2.2.2 TOP-DOWN APPROACH 44
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 45
2.4 MARKET SHARE ASSUMPTIONS 46
2.5 STUDY ASSUMPTIONS 46
2.6 RESEARCH LIMITATIONS 46
2.7 RISK ASSESSMENT 47
3 EXECUTIVE SUMMARY 48
4 PREMIUM INSIGHTS 52
4.1 ANTI-SNORING DEVICES MARKET OVERVIEW 52
4.2 GEOGRAPHIC GROWTH OPPORTUNITIES 55
5 MARKET OVERVIEW 56
5.1 INTRODUCTION 56
5.2 MARKET DYNAMICS 56
5.2.1 DRIVERS 57
5.2.1.1 Growing prevalence of sleep disorders 57
5.2.1.2 Increasing geriatric population and subsequent rise in obesity 58
5.2.1.3 Growing cigarette & alcohol consumption 58
5.2.1.4 Rising technological advancements in anti-snoring devices 59
5.2.2 RESTRAINTS 60
5.2.2.1 High price of customized oral appliances 60
5.2.2.2 Unreliable efficacy and inadequate studies for utilization
of anti-snoring devices 60
5.2.2.3 Social stigma associated with snoring 61
5.2.3 OPPORTUNITIES 61
5.2.3.1 Expanding undiagnosed population 61
5.2.3.2 High growth potential of emerging markets 62
5.2.4 CHALLENGES 62
5.2.4.1 Complex referral pathways and long waiting periods 62
5.3 PRICING ANALYSIS 63
5.3.1 AVERAGE SELLING PRICE OF ANTI-SNORING DEVICES, BY KEY PLAYER 63
5.3.2 AVERAGE SELLING PRICE TREND, BY DEVICE TYPE, 2021–2023 64
5.3.3 AVERAGE SELLING PRICE TREND OF ANTI-SNORING DEVICES
(ORAL APPLIANCES), BY REGION, 2021–2023 (USD) 65
5.4 VALUE CHAIN ANALYSIS 65
5.5 SUPPLY CHAIN ANALYSIS 66
5.6 ECOSYSTEM ANALYSIS 67
5.6.1 ANTI-SNORING DEVICES MARKET: ROLE IN ECOSYSTEM 68
5.7 PORTER’S FIVE FORCES ANALYSIS 69
5.7.1 THREAT OF NEW ENTRANTS 70
5.7.2 THREAT OF SUBSTITUTES 70
5.7.3 BARGAINING POWER OF SUPPLIERS 70
5.7.4 BARGAINING POWER OF BUYERS 70
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 70
5.8 REGULATORY ANALYSIS 71
5.8.1 REGULATORY LANDSCAPE 71
5.8.1.1 North America 71
5.8.1.1.1 US 71
5.8.1.1.1.1 Reimbursement scenario in US 72
5.8.1.1.2 Canada 73
5.8.1.2 Europe 73
5.8.1.3 Asia Pacific 74
5.8.1.3.1 Japan 74
5.8.1.3.2 China 74
5.8.1.3.3 India 75
5.8.1.3.4 Australia 76
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 76
5.8.2.1 North America 76
5.8.2.2 Europe 77
5.8.2.3 Asia Pacific 77
5.8.2.4 Latin America 78
5.8.2.5 Middle East & Africa 78
5.9 TECHNOLOGY ANALYSIS 79
5.9.1 KEY TECHNOLOGIES 79
5.9.1.1 Mandibular advancement devices 79
5.9.2 ADJACENT TECHNOLOGIES 79
5.9.2.1 Daytime-nighttime appliances 79
5.10 TRADE ANALYSIS 80
5.10.1 IMPORT DATA FOR HS CODE 901849, BY COUNTRY,
2019–2023 (USD MILLION) 80
5.10.2 EXPORT DATA FOR HS CODE 901849, BY COUNTRY,
2019–2023 (USD MILLION) 80
5.11 PATENT ANALYSIS 81
5.12 KEY CONFERENCES & EVENTS, 2024−2025 82
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 83
5.14 KEY STAKEHOLDERS & BUYING CRITERIA 83
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 83
5.14.2 BUYING CRITERIA 84
5.15 IMPACT OF AI/GENERATIVE AI ON ANTI-SNORING DEVICES MARKET 85
5.16 INVESTMENT & FUNDING SCENARIO 85
5.17 CASE STUDY ANALYSIS 86
6 ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE 87
6.1 INTRODUCTION 88
6.2 ORAL APPLIANCES 88
6.2.1 MANDIBULAR ADVANCEMENT DEVICES 93
6.2.1.1 Ready-made mandibular advancement devices 96
6.2.1.1.1 Low cost to fuel uptake 96
6.2.1.2 Custom-made mandibular advancement devices 98
6.2.1.2.1 High efficacy to drive market 98
6.3 TONGUE-RETAINING/STABILIZING DEVICES 101
6.3.1 LOWER SUCCESS RATE OF TRDS TO RESTRAIN MARKET 101
6.4 NASAL DEVICES 103
6.4.1 EXTERNAL NASAL DILATORS 105
6.4.1.1 Convenient and non-invasive benefits to boost demand 105
6.4.2 OTHER NASAL DEVICES 107
6.5 POSITION CONTROL DEVICES 110
6.6 CHIN STRAPS 112
6.7 EPAP THERAPY DEVICES 114
7 ANTI-SNORING DEVICES MARKET, BY GENDER 117
7.1 INTRODUCTION 118
7.2 MALE PATIENTS 119
7.2.1 HIGHER PREVALENCE OF OSA OWING TO ANATOMY VARIATIONS
TO PROPEL MARKET 119
7.3 FEMALE PATIENTS 121
7.3.1 RISING CASES OF UNDIAGNOSED OSA TO DRIVE MARKET 121
8 ANTI-SNORING DEVICES MARKET, BY AGE GROUP 123
8.1 INTRODUCTION 124
8.2 BELOW 40 YEARS 125
8.2.1 LOW PREVALENCE OF OSA AMONG YOUNGER INDIVIDUALS
TO RESTRAIN MARKET 125
8.3 BETWEEN 40–60 YEARS 127
8.3.1 INCREASING INCIDENCE OF CVD AND HYPERTENSION TO PROPEL MARKET 127
8.4 ABOVE 60 YEARS 129
8.4.1 CHANGING SLEEPING PATTERNS TO SUPPORT MARKET GROWTH 129
9 ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL 132
9.1 INTRODUCTION 133
9.2 ONLINE PHARMACIES 133
9.2.1 GROWING PREFERENCE FOR DIRECT DISTRIBUTION CHANNELS TO DRIVE MARKET 133
9.3 RETAIL PHARMACIES 136
9.3.1 CONVENIENT ACCESSIBILITY TO PRODUCTS TO PROPEL MARKET 136
9.4 HOSPITAL PHARMACIES 138
9.4.1 GROWING FOCUS ON PATIENT CONVENIENCE TO FUEL UPTAKE 138
10 ANTI-SNORING DEVICES MARKET, BY END USER 140
10.1 INTRODUCTION 141
10.2 HOME CARE SETTINGS 141
10.2.1 GROWING PATIENT PREFERENCE FOR ADVANCED SLEEP MONITORING DEVICES TO PROPEL MARKET 141
10.3 HOSPITALS & CLINICS 143
10.3.1 RAPID DEVELOPMENT IN HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET 143
11 ANTI-SNORING DEVICES MARKET, BY REGION 146
11.1 INTRODUCTION 147
11.2 NORTH AMERICA 148
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 148
11.2.2 US 153
11.2.2.1 Rising trend of remote sleep testing to fuel uptake 153
11.2.3 CANADA 157
11.2.3.1 Increasing number of research grants for sleep apnea devices to boost demand 157
11.3 EUROPE 160
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 161
11.3.2 GERMANY 164
11.3.2.1 High prevalence of smoking to boost demand 164
11.3.3 UK 168
11.3.3.1 Rising awareness and increasing number of sleep service groups to support market growth 168
11.3.4 FRANCE 171
11.3.4.1 Rising geriatric population to fuel uptake 171
11.3.5 ITALY 175
11.3.5.1 Favorable initiatives for treatment of OSA to support market growth 175
11.3.6 SPAIN 178
11.3.6.1 Increasing initiatives for social awareness by regional organizations for treatment to drive market 178
11.3.7 REST OF EUROPE 181
11.4 ASIA PACIFIC 185
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 185
11.4.2 CHINA 190
11.4.2.1 Growing adult obesity rates and expanding geriatric population to propel market 190
11.4.3 JAPAN 193
11.4.3.1 Rising demand for cloud-connected OSA therapy devices to boost demand 193
11.4.4 AUSTRALIA 196
11.4.4.1 Rising R&D initiatives for innovative sleep therapy devices to boost demand 196
11.4.5 REST OF ASIA PACIFIC 199
11.5 LATIN AMERICA 203
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 203
11.5.2 BRAZIL 207
11.5.2.1 Favorable reimbursement policies for advanced sleep apnea procedures to drive market 207
11.5.3 MEXICO 210
11.5.3.1 Poor healthcare infrastructure to limit market growth 210
11.5.4 REST OF LATIN AMERICA 213
11.6 MIDDLE EAST & AFRICA 216
11.6.1 PRESENCE OF GLOBAL PLAYERS AND HIGH INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET 216
11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 217
11.7 GCC COUNTRIES 220
11.7.1 HIGH OBESITY RATES TO SUPPORT MARKET GROWTH 220
11.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 221
12 COMPETITIVE LANDSCAPE 225
12.1 OVERVIEW 225
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 225
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ANTI-SNORING DEVICES MARKET 225
12.3 REVENUE ANALYSIS, 2019–2023 227
12.4 MARKET SHARE ANALYSIS, 2023 228
12.4.1 RANKING OF KEY MARKET PLAYERS 230
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 230
12.5.1 STARS 230
12.5.2 EMERGING LEADERS 230
12.5.3 PERVASIVE PLAYERS 230
12.5.4 PARTICIPANTS 230
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 232
12.5.5.1 Company footprint 232
12.5.5.2 Region footprint 233
12.5.5.3 Device footprint 234
12.5.5.4 Distribution channel footprint 234
12.5.5.5 End-user footprint 235
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 235
12.6.1 PROGRESSIVE COMPANIES 235
12.6.2 RESPONSIVE COMPANIES 235
12.6.3 DYNAMIC COMPANIES 236
12.6.4 STARTING BLOCKS 236
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 237
12.7 COMPANY VALUATION & FINANCIAL METRICS 238
12.7.1 FINANCIAL METRICS 238
12.7.2 COMPANY VALUATION 238
12.8 BRAND/PRODUCT COMPARISON 239
12.9 COMPETITIVE SCENARIO 240
12.9.1 PRODUCT LAUNCHES & APPROVALS 240
12.9.2 DEALS 241
12.9.3 EXPANSIONS 242
12.9.4 OTHER DEVELOPMENTS 242
13 COMPANY PROFILES 243
13.1 KEY PLAYERS 243
13.1.1 RESMED 243
13.1.1.1 Business overview 243
13.1.1.2 Products offered 245
13.1.1.3 Recent developments 245
13.1.1.3.1 Deals 245
13.1.1.3.2 Expansions 246
13.1.1.4 MnM view 246
13.1.1.4.1 Key strengths 246
13.1.1.4.2 Strategic choices 246
13.1.1.4.3 Weaknesses & competitive threats 246
13.1.2 SOMNOMED 247
13.1.2.1 Business overview 247
13.1.2.2 Products offered 248
13.1.2.3 MnM view 248
13.1.2.3.1 Key strengths 248
13.1.2.3.2 Strategic choices 248
13.1.2.3.3 Weaknesses & competitive threats 248
13.1.3 PROSOMNUS SLEEP TECHNOLOGIES 249
13.1.3.1 Business overview 249
13.1.3.2 Products offered 250
13.1.3.3 Recent developments 250
13.1.3.3.1 Deals 250
13.1.3.4 MnM view 250
13.1.3.4.1 Key strengths 250
13.1.3.4.2 Strategic choices 250
13.1.3.4.3 Weaknesses & competitive threats 251
13.1.4 VIVOS THERAPEUTICS, INC. 252
13.1.4.1 Business overview 252
13.1.4.2 Products offered 253
13.1.4.3 Recent developments 253
13.1.4.3.1 Product approvals 253
13.1.4.3.2 Deals 253
13.1.4.3.3 Expansions 254
13.1.4.3.4 Other developments 254
13.1.5 DYNAFLEX 255
13.1.5.1 Business overview 255
13.1.5.2 Products offered 255
13.1.5.3 Recent developments 256
13.1.5.3.1 Deals 256
13.1.6 OPENAIRWAY 257
13.1.6.1 Business overview 257
13.1.6.2 Products offered 257
13.1.6.3 Recent developments 257
13.1.6.3.1 Deals 257
13.1.7 PANTHERA DENTAL 258
13.1.7.1 Business overview 258
13.1.7.2 Products offered 258
13.1.7.3 Recent developments 258
13.1.7.3.1 Product launches 258
13.1.7.3.2 Deals 259
13.1.7.3.3 Other developments 259
13.1.8 AIRWAY MANAGEMENT 260
13.1.8.1 Business overview 260
13.1.8.2 Products offered 260
13.1.8.3 Recent developments 260
13.1.8.3.1 Product launches 260
13.1.9 APNEA SCIENCES 261
13.1.9.1 Business overview 261
13.1.9.2 Products offered 261
13.1.10 ORAVANOSA 262
13.1.10.1 Business overview 262
13.1.10.2 Products offered 262
13.1.11 MYERSON LLC 263
13.1.11.1 Business overview 263
13.1.11.2 Products offered 263
13.1.12 BRAEBON MEDICAL CORPORATION 264
13.1.12.1 Business overview 264
13.1.12.2 Products offered 264
13.2 OTHER PLAYERS 265
13.2.1 MPOWRX HEALTH & WELLNESS PRODUCTS 265
13.2.2 THE SNORE RELIEVER COMPANY, LLC 265
13.2.3 TOMED GMBH 266
13.2.4 THE AURUM GROUP 266
13.2.5 OSCIMED SA 267
13.2.6 SICAT GMBH & CO. KG 267
13.2.7 GLIDEWELL 268
13.2.8 APNOMED, INC. 269
13.2.9 ZQUIET 269
13.2.10 DREAM SYSTEMS DENTAL SLEEP LAB 270
13.2.11 PURE SLEEP COMPANY 270
13.2.12 THERAVENT, INC. 271
13.2.13 INNOVATIVE HEALTH TECHNOLOGIES 271
14 APPENDIX 272
14.1 DISCUSSION GUIDE 272
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 276
14.3 CUSTOMIZATION OPTIONS 278
14.4 RELATED REPORTS 278
14.5 AUTHOR DETAILS 279
LIST OF TABLES
TABLE 1 ANTI-SNORING DEVICES MARKET: INCLUSIONS & EXCLUSIONS 32
TABLE 2 ANTI-SNORING DEVICES MARKET: RISK ASSESSMENT ANALYSIS 47
TABLE 3 PREVALENCE OF SLEEP APNEA, BY COUNTRY, 2022–2024 57
TABLE 4 KEY STATISTICS ON AGING POPULATION 58
TABLE 5 LIST OF ADVANCED ORAL APPLIANCES AVAILABLE FOR TREATING SNORING 59
TABLE 6 INITIATIVES TO PROMOTE AWARENESS ABOUT EFFECTS OF UNTREATED SLEEP APNEA AND SNORING 59
TABLE 7 INADEQUATE EFFICACY STUDIES ASSOCIATED WITH USE OF ANTI-SNORING DEVICES 61
TABLE 8 KEY STATISTICS ON SNORING POPULATION 61
TABLE 9 HIGH GROWTH POTENTIAL IN EMERGING MARKETS DUE TO UNDIAGNOSED POPULATION 62
TABLE 10 AVERAGE SELLING PRICE OF ANTI-SNORING DEVICES, BY KEY PLAYER 63
TABLE 11 AVERAGE SELLING PRICE TREND, BY DEVICE TYPE, 2021–2023 64
TABLE 12 AVERAGE SELLING PRICE TREND OF ANTI-SNORING DEVICES (ORAL APPLIANCES), BY REGION, 2021–2023 (USD) 65
TABLE 13 ANTI-SNORING DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 69
TABLE 14 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 72
TABLE 15 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 73
TABLE 16 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 74
TABLE 17 CHINA: CLASSIFICATION OF MEDICAL DEVICES 75
TABLE 18 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 76
TABLE 19 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 77
TABLE 20 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 77
TABLE 21 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 78
TABLE 22 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 23 ANTI-SNORING DEVICES MARKET: DETAILED LIST OF CONFERENCES
& EVENTS, 2024−2025 82
TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ANTI-SNORING
DEVICES (%) 84
TABLE 25 KEY BUYING CRITERIA FOR END USERS OF ANTI-SNORING DEVICES 84
TABLE 26 ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 88
TABLE 27 ORAL APPLIANCES OFFERED BY KEY PLAYERS 89
TABLE 28 ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 89
TABLE 29 ORAL APPLIANCES MARKET, BY REGION, 2022–2029 (USD MILLION) 90
TABLE 30 NORTH AMERICA: ORAL APPLIANCES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 90
TABLE 31 NORTH AMERICA: ORAL APPLIANCES MARKET, BY COUNTRY,
2022–2029 (THOUSAND UNITS) 90
TABLE 32 EUROPE ORAL APPLIANCES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 91
TABLE 33 EUROPE: ORAL APPLIANCES MARKET, BY COUNTRY,
2022–2029 (THOUSAND UNITS) 91
TABLE 34 ASIA PACIFIC: ORAL APPLIANCES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 92
TABLE 35 ASIA PACIFIC: ORAL APPLIANCES MARKET, BY COUNTRY,
2022–2029 (THOUSAND UNITS) 92
TABLE 36 LATIN AMERICA: ORAL APPLIANCES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 92
TABLE 37 MANDIBULAR ADVANCEMENT DEVICES OFFERED BY KEY PLAYERS 93
TABLE 38 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 94
TABLE 39 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION,
2022–2029 (USD MILLION) 94
TABLE 40 NORTH AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 94
TABLE 41 EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 95
TABLE 42 ASIA PACIFIC: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 95
TABLE 43 LATIN AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 95
TABLE 44 READY-MADE MANDIBULAR ADVANCEMENT DEVICES OFFERED BY KEY PLAYERS 96
TABLE 45 READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY REGION, 2022–2029 (USD MILLION) 96
TABLE 46 NORTH AMERICA: READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 97
TABLE 47 EUROPE: READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 97
TABLE 48 ASIA PACIFIC: READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 97
TABLE 49 LATIN AMERICA: READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 98
TABLE 50 CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES OFFERED BY KEY PLAYERS 98
TABLE 51 CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY REGION, 2022–2029 (USD MILLION) 99
TABLE 52 NORTH AMERICA: CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 99
TABLE 53 EUROPE: CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 100
TABLE 54 ASIA PACIFIC: CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 100
TABLE 55 LATIN AMERICA: CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 100
TABLE 56 TONGUE-RETAINING DEVICES OFFERED BY KEY PLAYERS 101
TABLE 57 TONGUE-RETAINING/STABILIZING DEVICES MARKET,
BY REGION, 2022–2029 (USD MILLION) 101
TABLE 58 NORTH AMERICA: TONGUE-RETAINING/STABILIZING DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 102
TABLE 59 EUROPE: TONGUE-RETAINING/STABILIZING DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 102
TABLE 60 ASIA PACIFIC: TONGUE-RETAINING/STABILIZING DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 102
TABLE 61 LATIN AMERICA: TONGUE-RETAINING/STABILIZING DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 103
TABLE 62 NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 103
TABLE 63 NASAL DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 104
TABLE 64 NORTH AMERICA: NASAL DEVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 104
TABLE 65 EUROPE: NASAL DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 104
TABLE 66 ASIA PACIFIC: NASAL DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 105
TABLE 67 LATIN AMERICA: NASAL DEVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 105
TABLE 68 EXTERNAL NASAL DILATORS MARKET, BY REGION, 2022–2029 (USD MILLION) 106
TABLE 69 NORTH AMERICA: EXTERNAL NASAL DILATORS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 106
TABLE 70 EUROPE: EXTERNAL NASAL DILATORS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 106
TABLE 71 ASIA PACIFIC: EXTERNAL NASAL DILATORS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 107
TABLE 72 LATIN AMERICA: EXTERNAL NASAL DILATORS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 107
TABLE 73 OTHER NASAL DEVICES 108
TABLE 74 OTHER NASAL DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 108
TABLE 75 NORTH AMERICA: OTHER NASAL DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 109
TABLE 76 EUROPE: OTHER NASAL DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 109
TABLE 77 ASIA PACIFIC: OTHER NASAL DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 109
TABLE 78 LATIN AMERICA: OTHER NASAL DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 110
TABLE 79 POSITION CONTROL DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 110
TABLE 80 NORTH AMERICA: POSITION CONTROL DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 111
TABLE 81 EUROPE: POSITION CONTROL DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 111
TABLE 82 ASIA PACIFIC: POSITION CONTROL DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 111
TABLE 83 LATIN AMERICA: POSITION CONTROL DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 112
TABLE 84 CHIN STRAPS MARKET, BY REGION, 2022–2029 (USD MILLION) 112
TABLE 85 NORTH AMERICA: CHIN STRAPS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 113
TABLE 86 EUROPE: CHIN STRAPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 113
TABLE 87 ASIA PACIFIC: CHIN STRAPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 113
TABLE 88 LATIN AMERICA: CHIN STRAPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 114
TABLE 89 EPAP THERAPY DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 114
TABLE 90 NORTH AMERICA: EPAP THERAPY DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 115
TABLE 91 EUROPE: EPAP THERAPY DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 115
TABLE 92 ASIA PACIFIC: EPAP THERAPY DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 115
TABLE 93 LATIN AMERICA: EPAP THERAPY DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 116
TABLE 94 PREVALENCE OF SLEEP APNEA, BY AGE GROUP AND GENDER 118
TABLE 95 ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 118
TABLE 96 ANTI-SNORING DEVICES MARKET FOR MALE PATIENTS,
BY REGION, 2022–2029 (USD MILLION) 119
TABLE 97 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR MALE PATIENTS,
BY COUNTRY, 2022–2029 (USD MILLION) 119
TABLE 98 EUROPE: ANTI-SNORING DEVICES MARKET FOR MALE PATIENTS,
BY COUNTRY, 2022–2029 (USD MILLION) 120
TABLE 99 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR MALE PATIENTS,
BY COUNTRY, 2022–2029 (USD MILLION) 120
TABLE 100 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR MALE PATIENTS,
BY COUNTRY, 2022–2029 (USD MILLION) 120
TABLE 101 ANTI-SNORING DEVICES MARKET FOR FEMALE PATIENTS,
BY REGION, 2022–2029 (USD MILLION) 121
TABLE 102 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR FEMALE PATIENTS,
BY COUNTRY, 2022–2029 (USD MILLION) 121
TABLE 103 EUROPE: ANTI-SNORING DEVICES MARKET FOR FEMALE PATIENTS,
BY COUNTRY, 2022–2029 (USD MILLION) 122
TABLE 104 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR FEMALE PATIENTS,
BY COUNTRY, 2022–2029 (USD MILLION) 122
TABLE 105 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR FEMALE PATIENTS,
BY COUNTRY, 2022–2029 (USD MILLION) 122
TABLE 106 PREVALENCE OF SLEEP APNEA, BY AGE GROUP (2022) 124
TABLE 107 ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 124
TABLE 108 ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS UNDER 40 YEARS,
BY REGION, 2022–2029 (USD MILLION) 125
TABLE 109 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS
UNDER 40 YEARS, BY COUNTRY, 2022–2029 (USD MILLION) 125
TABLE 110 EUROPE: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS
UNDER 40 YEARS, BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 111 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS
UNDER 40 YEARS, BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 112 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS
UNDER 40 YEARS, BY COUNTRY, 2022–2029 (USD MILLION) 127
TABLE 113 ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS
BETWEEN 40–60 YEARS, BY REGION, 2022–2029 (USD MILLION) 127
TABLE 114 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS
BETWEEN 40–60 YEARS, BY COUNTRY, 2022–2029 (USD MILLION) 128
TABLE 115 EUROPE: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS
BETWEEN 40–60 YEARS, BY COUNTRY, 2022–2029 (USD MILLION) 128
TABLE 116 ASIA PACIFIC: 40–60 YEARS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 128
TABLE 117 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS
BETWEEN 40–60 YEARS, BY COUNTRY, 2022–2029 (USD MILLION) 129
TABLE 118 ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS ABOVE 60 YEARS,
BY REGION, 2022–2029 (USD MILLION) 129
TABLE 119 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS
ABOVE 60 YEARS, BY COUNTRY, 2022–2029 (USD MILLION) 130
TABLE 120 EUROPE: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS
ABOVE 60 YEARS, BY COUNTRY, 2022–2029 (USD MILLION) 130
TABLE 121 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS
ABOVE 60 YEARS, BY COUNTRY, 2022–2029 (USD MILLION) 130
TABLE 122 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS
ABOVE 60 YEARS, BY COUNTRY, 2022–2029 (USD MILLION) 131
TABLE 123 ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL,
2022–2029 (USD MILLION) 133
TABLE 124 ANTI-SNORING DEVICES MARKET FOR ONLINE PHARMACIES,
BY REGION, 2022–2029 (USD MILLION) 134
TABLE 125 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR ONLINE PHARMACIES,
BY COUNTRY, 2022–2029 (USD MILLION) 134
TABLE 126 EUROPE: ANTI-SNORING DEVICES MARKET FOR ONLINE PHARMACIES,
BY COUNTRY, 2022–2029 (USD MILLION) 135
TABLE 127 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR ONLINE PHARMACIES,
BY COUNTRY, 2022–2029 (USD MILLION) 135
TABLE 128 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR ONLINE PHARMACIES,
BY COUNTRY, 2022–2029 (USD MILLION) 135
TABLE 129 ANTI-SNORING DEVICES MARKET FOR RETAIL PHARMACIES,
BY REGION, 2022–2029 (USD MILLION) 136
TABLE 130 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR RETAIL PHARMACIES,
BY COUNTRY, 2022–2029 (USD MILLION) 136
TABLE 131 EUROPE: ANTI-SNORING DEVICES MARKET FOR RETAIL PHARMACIES,
BY COUNTRY, 2022–2029 (USD MILLION) 137
TABLE 132 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR RETAIL PHARMACIES,
BY COUNTRY, 2022–2029 (USD MILLION) 137
TABLE 133 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR RETAIL PHARMACIES,
BY COUNTRY, 2022–2029 (USD MILLION) 137
TABLE 134 ANTI-SNORING DEVICES MARKET FOR HOSPITAL PHARMACIES,
BY REGION, 2022–2029 (USD MILLION) 138
TABLE 135 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION) 138
TABLE 136 EUROPE: ANTI-SNORING DEVICES MARKET FOR HOSPITAL PHARMACIES,
BY COUNTRY, 2022–2029 (USD MILLION) 139
TABLE 137 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR HOSPITAL PHARMACIES,
BY COUNTRY, 2022–2029 (USD MILLION) 139
TABLE 138 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR HOSPITAL PHARMACIES,
BY COUNTRY, 2022–2029 (USD MILLION) 139
TABLE 139 ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 141
TABLE 140 ANTI-SNORING DEVICES MARKET FOR HOME CARE SETTINGS,
BY REGION, 2022–2029 (USD MILLION) 141
TABLE 141 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION) 142
TABLE 142 EUROPE: ANTI-SNORING DEVICES MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2022–2029 (USD MILLION) 142
TABLE 143 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2022–2029 (USD MILLION) 142
TABLE 144 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2022–2029 (USD MILLION) 143
TABLE 145 ANTI-SNORING DEVICES MARKET FOR HOSPITALS & CLINICS,
BY REGION, 2022–2029 (USD MILLION) 144
TABLE 146 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR HOSPITALS & CLINICS,
BY COUNTRY, 2022–2029 (USD MILLION) 144
TABLE 147 EUROPE: ANTI-SNORING DEVICES MARKET FOR HOSPITALS & CLINICS,
BY COUNTRY, 2022–2029 (USD MILLION) 145
TABLE 148 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR HOSPITALS & CLINICS,
BY COUNTRY, 2022–2029 (USD MILLION) 145
TABLE 149 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR HOSPITALS & CLINICS,
BY COUNTRY, 2022–2029 (USD MILLION) 145
TABLE 150 ANTI-SNORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 147
TABLE 151 NORTH AMERICA: MACROECONOMIC INDICATORS 148
TABLE 152 NORTH AMERICA: ANTI-SNORING DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 150
TABLE 153 NORTH AMERICA: ANTI-SNORING DEVICES MARKET,
BY DEVICE TYPE, 2022–2029 (USD MILLION) 150
TABLE 154 NORTH AMERICA: ORAL APPLIANCES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 150
TABLE 155 NORTH AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 151
TABLE 156 NORTH AMERICA: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 151
TABLE 157 NORTH AMERICA: ANTI-SNORING DEVICES MARKET,
BY GENDER, 2022–2029 (USD MILLION) 151
TABLE 158 NORTH AMERICA: ANTI-SNORING DEVICES MARKET,
BY AGE GROUP, 2022–2029 (USD MILLION) 152
TABLE 159 NORTH AMERICA: ANTI-SNORING DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 152
TABLE 160 NORTH AMERICA: ANTI-SNORING DEVICES MARKET,
BY END USER, 2022–2029 (USD MILLION) 152
TABLE 161 KEY ANTI-SNORING PRODUCTS PROVIDED BY LEADING PLAYERS IN US 154
TABLE 162 US: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE,
2022–2029 (USD MILLION) 154
TABLE 163 US: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 154
TABLE 164 US: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 155
TABLE 165 US: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 155
TABLE 166 US: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 155
TABLE 167 US: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 156
TABLE 168 US: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL,
2022–2029 (USD MILLION) 156
TABLE 169 US: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 156
TABLE 170 KEY ANTI-SNORING PRODUCTS PROVIDED BY LEADING PLAYERS IN CANADA 157
TABLE 171 CANADA: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE,
2022–2029 (USD MILLION) 158
TABLE 172 CANADA: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 158
TABLE 173 CANADA: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 158
TABLE 174 CANADA: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 159
TABLE 175 CANADA: ANTI-SNORING DEVICES MARKET,
BY GENDER, 2022–2029 (USD MILLION) 159
TABLE 176 CANADA: ANTI-SNORING DEVICES MARKET,
BY AGE GROUP, 2022–2029 (USD MILLION) 159
TABLE 177 CANADA: ANTI-SNORING DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 160
TABLE 178 CANADA: ANTI-SNORING DEVICES MARKET,
BY END USER, 2022–2029 (USD MILLION) 160
TABLE 179 EUROPE: MACROECONOMIC INDICATORS 161
TABLE 180 EUROPE: ANTI-SNORING DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 181 EUROPE: ANTI-SNORING DEVICES MARKET,
BY DEVICE TYPE, 2022–2029 (USD MILLION) 162
TABLE 182 EUROPE: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 162
TABLE 183 EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 162
TABLE 184 EUROPE: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 163
TABLE 185 EUROPE: ANTI-SNORING DEVICES MARKET,
BY GENDER, 2022–2029 (USD MILLION) 163
TABLE 186 EUROPE: ANTI-SNORING DEVICES MARKET,
BY AGE GROUP, 2022–2029 (USD MILLION) 163
TABLE 187 EUROPE: ANTI-SNORING DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 164
TABLE 188 EUROPE: ANTI-SNORING DEVICES MARKET,
BY END USER, 2022–2029 (USD MILLION) 164
TABLE 189 ANTI-SNORING PRODUCTS PROVIDED BY LEADING PLAYERS IN GERMANY 165
TABLE 190 GERMANY: ANTI-SNORING DEVICES MARKET,
BY DEVICE TYPE, 2022–2029 (USD MILLION) 165
TABLE 191 GERMANY: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 166
TABLE 192 GERMANY: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 166
TABLE 193 GERMANY: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 166
TABLE 194 GERMANY: ANTI-SNORING DEVICES MARKET,
BY GENDER, 2022–2029 (USD MILLION) 167
TABLE 195 GERMANY: ANTI-SNORING DEVICES MARKET,
BY AGE GROUP, 2022–2029 (USD MILLION) 167
TABLE 196 GERMANY: ANTI-SNORING DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 167
TABLE 197 GERMANY: ANTI-SNORING DEVICES MARKET,
BY END USER, 2022–2029 (USD MILLION) 168
TABLE 198 UK: ANTI-SNORING DEVICES MARKET,
BY DEVICE TYPE, 2022–2029 (USD MILLION) 169
TABLE 199 UK: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 169
TABLE 200 UK: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 169
TABLE 201 UK: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 170
TABLE 202 UK: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 170
TABLE 203 UK: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 170
TABLE 204 UK: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL,
2022–2029 (USD MILLION) 171
TABLE 205 UK: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 171
TABLE 206 MAJOR PLAYERS THAT ARE REIMBURSED BY SOCIAL SECURITY OF FRANCE 172
TABLE 207 FRANCE: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE,
2022–2029 (USD MILLION) 172
TABLE 208 FRANCE: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 172
TABLE 209 FRANCE: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 173
TABLE 210 FRANCE: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 173
TABLE 211 FRANCE: ANTI-SNORING DEVICES MARKET,
BY GENDER, 2022–2029 (USD MILLION) 173
TABLE 212 FRANCE: ANTI-SNORING DEVICES MARKET,
BY AGE GROUP, 2022–2029 (USD MILLION) 174
TABLE 213 FRANCE: ANTI-SNORING DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 174
TABLE 214 FRANCE: ANTI-SNORING DEVICES MARKET,
BY END USER, 2022–2029 (USD MILLION) 174
TABLE 215 ITALY: ANTI-SNORING DEVICES MARKET,
BY DEVICE TYPE, 2022–2029 (USD MILLION) 175
TABLE 216 ITALY: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 176
TABLE 217 ITALY: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 176
TABLE 218 ITALY: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 176
TABLE 219 ITALY: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 177
TABLE 220 ITALY: ANTI-SNORING DEVICES MARKET,
BY AGE GROUP, 2022–2029 (USD MILLION) 177
TABLE 221 ITALY: ANTI-SNORING DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 177
TABLE 222 ITALY: ANTI-SNORING DEVICES MARKET,
BY END USER, 2022–2029 (USD MILLION) 178
TABLE 223 SPAIN: ANTI-SNORING DEVICES MARKET,
BY DEVICE TYPE, 2022–2029 (USD MILLION) 179
TABLE 224 SPAIN: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 179
TABLE 225 SPAIN: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 179
TABLE 226 SPAIN: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 180
TABLE 227 SPAIN: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 180
TABLE 228 SPAIN: ANTI-SNORING DEVICES MARKET, BY AGE GROUP,
2022–2029 (USD MILLION) 180
TABLE 229 SPAIN: ANTI-SNORING DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 181
TABLE 230 SPAIN: ANTI-SNORING DEVICES MARKET, BY END USER,
2022–2029 (USD MILLION) 181
TABLE 231 REST OF EUROPE: ANTI-SNORING DEVICES MARKET,
BY DEVICE TYPE, 2022–2029 (USD MILLION) 182
TABLE 232 REST OF EUROPE: ORAL APPLIANCES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 182
TABLE 233 REST OF EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 182
TABLE 234 REST OF EUROPE: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 183
TABLE 235 REST OF EUROPE: ANTI-SNORING DEVICES MARKET,
BY GENDER, 2022–2029 (USD MILLION) 183
TABLE 236 REST OF EUROPE: ANTI-SNORING DEVICES MARKET,
BY AGE GROUP, 2022–2029 (USD MILLION) 183
TABLE 237 REST OF EUROPE: ANTI-SNORING DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 184
TABLE 238 REST OF EUROPE: ANTI-SNORING DEVICES MARKET,
BY END USER, 2022–2029 (USD MILLION) 184
TABLE 239 ASIA PACIFIC: MACROECONOMIC INDICATORS 185
TABLE 240 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 187
TABLE 241 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET,
BY DEVICE TYPE, 2022–2029 (USD MILLION) 187
TABLE 242 ASIA PACIFIC: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 187
TABLE 243 ASIA PACIFIC: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 188
TABLE 244 ASIA PACIFIC: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 188
TABLE 245 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET,
BY GENDER, 2022–2029 (USD MILLION) 188
TABLE 246 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET,
BY AGE GROUP, 2022–2029 (USD MILLION) 189
TABLE 247 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 189
TABLE 248 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET,
BY END USER, 2022–2029 (USD MILLION) 189
TABLE 249 CHINA: ANTI-SNORING DEVICES MARKET,
BY DEVICE TYPE, 2022–2029 (USD MILLION) 190
TABLE 250 CHINA: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 191
TABLE 251 CHINA: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 191
TABLE 252 CHINA: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 191
TABLE 253 CHINA: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 192
TABLE 254 CHINA: ANTI-SNORING DEVICES MARKET,
BY AGE GROUP, 2022–2029 (USD MILLION) 192
TABLE 255 CHINA: ANTI-SNORING DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 192
TABLE 256 CHINA: ANTI-SNORING DEVICES MARKET,
BY END USER, 2022–2029 (USD MILLION) 193
TABLE 257 JAPAN: ANTI-SNORING DEVICES MARKET,
BY DEVICE TYPE, 2022–2029 (USD MILLION) 193
TABLE 258 JAPAN: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 194
TABLE 259 JAPAN: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 194
TABLE 260 JAPAN: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 194
TABLE 261 JAPAN: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 195
TABLE 262 JAPAN: ANTI-SNORING DEVICES MARKET,
BY AGE GROUP, 2022–2029 (USD MILLION) 195
TABLE 263 JAPAN: ANTI-SNORING DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 195
TABLE 264 JAPAN: ANTI-SNORING DEVICES MARKET,
BY END USER, 2022–2029 (USD MILLION) 196
TABLE 265 AUSTRALIA: ANTI-SNORING DEVICES MARKET,
BY DEVICE TYPE, 2022–2029 (USD MILLION) 197
TABLE 266 AUSTRALIA: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 197
TABLE 267 AUSTRALIA: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 197
TABLE 268 AUSTRALIA: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 198
TABLE 269 AUSTRALIA: ANTI-SNORING DEVICES MARKET,
BY GENDER, 2022–2029 (USD MILLION) 198
TABLE 270 AUSTRALIA: ANTI-SNORING DEVICES MARKET,
BY AGE GROUP, 2022–2029 (USD MILLION) 198
TABLE 271 AUSTRALIA: ANTI-SNORING DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 199
TABLE 272 AUSTRALIA: ANTI-SNORING DEVICES MARKET,
BY END USER, 2022–2029 (USD MILLION) 199
TABLE 273 REST OF ASIA PACIFIC: ANTI-SNORING DEVICES MARKET,
BY DEVICE TYPE, 2022–2029 (USD MILLION) 200
TABLE 274 REST OF ASIA PACIFIC: ORAL APPLIANCES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 200
TABLE 275 REST OF ASIA PACIFIC: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 201
TABLE 276 REST OF ASIA PACIFIC: NASAL DEVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 201
TABLE 277 REST OF ASIA PACIFIC: ANTI-SNORING DEVICES MARKET,
BY GENDER, 2022–2029 (USD MILLION) 201
TABLE 278 REST OF ASIA PACIFIC: ANTI-SNORING DEVICES MARKET,
BY AGE GROUP, 2022–2029 (USD MILLION) 202
TABLE 279 REST OF ASIA PACIFIC: ANTI-SNORING DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 202
TABLE 280 REST OF ASIA PACIFIC: ANTI-SNORING DEVICES MARKET,
BY END USER, 2022–2029 (USD MILLION) 202
TABLE 281 LATIN AMERICA: MACROECONOMIC INDICATORS 203
TABLE 282 LATIN AMERICA: ANTI-SNORING DEVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 204
TABLE 283 LATIN AMERICA: ANTI-SNORING DEVICES MARKET,
BY DEVICE TYPE, 2022–2029 (USD MILLION) 204
TABLE 284 LATIN AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 205
TABLE 285 LATIN AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 205
TABLE 286 LATIN AMERICA: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 205
TABLE 287 LATIN AMERICA: ANTI-SNORING DEVICES MARKET,
BY GENDER, 2022–2029 (USD MILLION) 206
TABLE 288 LATIN AMERICA: ANTI-SNORING DEVICES MARKET,
BY AGE GROUP, 2022–2029 (USD MILLION) 206
TABLE 289 LATIN AMERICA: ANTI-SNORING DEVICES MARKET, B
Y DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 206
TABLE 290 LATIN AMERICA: ANTI-SNORING DEVICES MARKET,
BY END USER, 2022–2029 (USD MILLION) 207
TABLE 291 BRAZIL: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE,
2022–2029 (USD MILLION) 208
TABLE 292 BRAZIL: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 208
TABLE 293 BRAZIL: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 208
TABLE 294 BRAZIL: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 209
TABLE 295 BRAZIL: ANTI-SNORING DEVICES MARKET, BY GENDER,
2022–2029 (USD MILLION) 209
TABLE 296 BRAZIL: ANTI-SNORING DEVICES MARKET, BY AGE GROUP,
2022–2029 (USD MILLION) 209
TABLE 297 BRAZIL: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL,
2022–2029 (USD MILLION) 210
TABLE 298 BRAZIL: ANTI-SNORING DEVICES MARKET, BY END USER,
2022–2029 (USD MILLION) 210
TABLE 299 MEXICO: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE,
2022–2029 (USD MILLION) 211
TABLE 300 MEXICO: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 211
TABLE 301 MEXICO: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 211
TABLE 302 MEXICO: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 212
TABLE 303 MEXICO: ANTI-SNORING DEVICES MARKET,
BY GENDER, 2022–2029 (USD MILLION) 212
TABLE 304 MEXICO: ANTI-SNORING DEVICES MARKET,
BY AGE GROUP, 2022–2029 (USD MILLION) 212
TABLE 305 MEXICO: ANTI-SNORING DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 213
TABLE 306 MEXICO: ANTI-SNORING DEVICES MARKET,
BY END USER, 2022–2029 (USD MILLION) 213
TABLE 307 REST OF LATIN AMERICA: ANTI-SNORING DEVICES MARKET,
BY DEVICE TYPE, 2022–2029 (USD MILLION) 214
TABLE 308 REST OF LATIN AMERICA: ORAL APPLIANCES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 214
TABLE 309 REST OF LATIN AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 214
TABLE 310 REST OF LATIN AMERICA: NASAL DEVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 215
TABLE 311 REST OF LATIN AMERICA: ANTI-SNORING DEVICES MARKET,
BY GENDER, 2022–2029 (USD MILLION) 215
TABLE 312 REST OF LATIN AMERICA: ANTI-SNORING DEVICES MARKET,
BY AGE GROUP, 2022–2029 (USD MILLION) 215
TABLE 313 REST OF LATIN AMERICA: ANTI-SNORING DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 216
TABLE 314 REST OF LATIN AMERICA: ANTI-SNORING DEVICES MARKET,
BY END USER, 2022–2029 (USD MILLION) 216
TABLE 315 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 217
TABLE 316 MIDDLE EAST & AFRICA: ANTI-SNORING DEVICES MARKET,
BY DEVICE TYPE, 2022–2029 (USD MILLION) 217
TABLE 317 MIDDLE EAST & AFRICA: ORAL APPLIANCES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 218
TABLE 318 MIDDLE EAST & AFRICA: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 218
TABLE 319 MIDDLE EAST & AFRICA: NASAL DEVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 218
TABLE 320 MIDDLE EAST & AFRICA: ANTI-SNORING DEVICES MARKET,
BY GENDER, 2022–2029 (USD MILLION) 219
TABLE 321 MIDDLE EAST & AFRICA: ANTI-SNORING DEVICES MARKET,
BY AGE GROUP, 2022–2029 (USD MILLION) 219
TABLE 322 MIDDLE EAST & AFRICA: ANTI-SNORING DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 219
TABLE 323 MIDDLE EAST & AFRICA: ANTI-SNORING DEVICES MARKET,
BY END USER, 2022–2029 (USD MILLION) 220
TABLE 324 GCC COUNTRIES: MACROECONOMIC INDICATORS 221
TABLE 325 GCC COUNTRIES: ANTI-SNORING DEVICES MARKET,
BY DEVICE TYPE, 2022–2029 (USD MILLION) 221
TABLE 326 GCC COUNTRIES: ORAL APPLIANCES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 222
TABLE 327 GCC COUNTRIES: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION) 222
TABLE 328 GCC COUNTRIES: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 222
TABLE 329 GCC COUNTRIES: ANTI-SNORING DEVICES MARKET,
BY GENDER, 2022–2029 (USD MILLION) 223
TABLE 330 GCC COUNTRIES: ANTI-SNORING DEVICES MARKET,
BY AGE GROUP, 2022–2029 (USD MILLION) 223
TABLE 331 GCC COUNTRIES: ANTI-SNORING DEVICES MARKET,
BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 223
TABLE 332 GCC COUNTRIES: ANTI-SNORING DEVICES MARKET,
BY END USER, 2022–2029 (USD MILLION) 224
TABLE 333 OVERVIEW OF STRATEGIES DEPLOYED BY KEY ANTI-SNORING DEVICE MANUFACTURING COMPANIES 225
TABLE 334 ANTI-SNORING DEVICES MARKET: DEGREE OF COMPETITION 229
TABLE 335 ANTI-SNORING DEVICES MARKET: REGION FOOTPRINT 233
TABLE 336 ANTI-SNORING DEVICES MARKET: DEVICE FOOTPRINT 234
TABLE 337 ANTI-SNORING DEVICES MARKET: DISTRIBUTION CHANNEL FOOTPRINT 234
TABLE 338 ANTI-SNORING DEVICES MARKET: END-USER FOOTPRINT 235
TABLE 339 ANTI-SNORING DEVICES MARKET: DETAILED LIST OF
KEY STARTUPS/SME PLAYERS 237
TABLE 340 ANTI-SNORING DEVICES MARKET: COMPETITIVE BENCHMARKING OF
KEY STARTUPS/SMES 237
TABLE 341 ANTI-SNORING DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–NOVEMBER 2024 240
TABLE 342 ANTI-SNORING DEVICES MARKET: DEALS, JANUARY 2021–NOVEMBER 2024 241
TABLE 343 ANTI-SNORING DEVICES MARKET: EXPANSIONS, JANUARY 2021–NOVEMBER 2024 242
TABLE 344 ANTI-SNORING DEVICES MARKET: OTHER DEVELOPMENTS,
JANUARY 2021–NOVEMBER 2024 242
TABLE 345 RESMED: COMPANY OVERVIEW 243
TABLE 346 RESMED: PRODUCTS OFFERED 245
TABLE 347 RESMED: DEALS, JANUARY 2021–NOVEMBER 2024 245
TABLE 348 RESMED: EXPANSIONS, JANUARY 2021–NOVEMBER 2024 246
TABLE 349 SOMNOMED: COMPANY OVERVIEW 247
TABLE 350 SOMNOMED: PRODUCTS OFFERED 248
TABLE 351 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY OVERVIEW 249
TABLE 352 PROSOMNUS SLEEP TECHNOLOGIES: PRODUCTS OFFERED 250
TABLE 353 PROSOMNUS SLEEP TECHNOLOGIES: DEALS, JANUARY 2021–NOVEMBER 2024 250
TABLE 354 VIVOS THERAPEUTICS, INC.: COMPANY OVERVIEW 252
TABLE 355 VIVOS THERAPEUTICS, INC.: PRODUCTS OFFERED 253
TABLE 356 VIVOS THERAPEUTICS, INC.: PRODUCT APPROVALS, JANUARY 2021–MARCH 2024 253
TABLE 357 VIVOS THERAPEUTICS, INC.: DEALS, JANUARY 2021–NOVEMBER 2024 253
TABLE 358 VIVOS THERAPEUTICS, INC.: EXPANSIONS, JANUARY 2021–NOVEMBER 2024 254
TABLE 359 VIVOS THERAPEUTICS, INC.: OTHER DEVELOPMENTS,
JANUARY 2021–NOVEMBER 2024 254
TABLE 360 DYNAFLEX: COMPANY OVERVIEW 255
TABLE 361 DYNAFLEX: PRODUCTS OFFERED 255
TABLE 362 DYNAFLEX: DEALS, JANUARY 2021–NOVEMBER 2024 256
TABLE 363 OPENAIRWAY: COMPANY OVERVIEW 257
TABLE 364 OPENAIRWAY: PRODUCTS OFFERED 257
TABLE 365 OPENAIRWAY: DEALS, JANUARY 2021–NOVEMBER 2024 257
TABLE 366 PANTHERA DENTAL: COMPANY OVERVIEW 258
TABLE 367 PANTHERA DENTAL: PRODUCTS OFFERED 258
TABLE 368 PANTHERA DENTAL: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 258
TABLE 369 PANTHERA DENTAL: DEALS, JANUARY 2021–NOVEMBER 2024 259
TABLE 370 PANTHERA DENTAL: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2024 259
TABLE 371 AIRWAY MANAGEMENT: COMPANY OVERVIEW 260
TABLE 372 AIRWAY MANAGEMENT: PRODUCTS OFFERED 260
TABLE 373 AIRWAY MANAGEMENT: PRODUCT LAUNCHES, JANUARY 2021−NOVEMBER 2024 260
TABLE 374 APNEA SCIENCES: COMPANY OVERVIEW 261
TABLE 375 APNEA SCIENCES: PRODUCTS OFFERED 261
TABLE 376 ORAVANOSA: COMPANY OVERVIEW 262
TABLE 377 ORAVANOSA: PRODUCTS OFFERED 262
TABLE 378 MYERSON LLC: COMPANY OVERVIEW 263
TABLE 379 MYERSON LLC: PRODUCTS OFFERED 263
TABLE 380 BRAEBON MEDICAL CORPORATION: COMPANY OVERVIEW 264
TABLE 381 BRAEBON MEDICAL CORPORATION: PRODUCTS OFFERED 264
LIST OF FIGURES
FIGURE 1 MARKETS & REGIONS COVERED 31
FIGURE 2 ANTI-SNORING DEVICES MARKET: RESEARCH DESIGN 35
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 40
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 41
FIGURE 5 BOTTOM-UP APPROACH: PATIENT-BASED ANALYSIS 42
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 43
FIGURE 7 ANTI-SNORING DEVICES MARKET: TOP-DOWN APPROACH 44
FIGURE 8 DATA TRIANGULATION METHODOLOGY 45
FIGURE 9 ANTI-SNORING DEVICES MARKET: STUDY ASSUMPTIONS 46
FIGURE 10 ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2024 VS. 2029 (USD MILLION) 48
FIGURE 11 ANTI-SNORING DEVICES MARKET, BY GENDER, 2024 VS. 2029 (USD MILLION) 49
FIGURE 12 ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2024 VS. 2029 (USD MILLION) 49
FIGURE 13 ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL,
2024 VS. 2029 (USD MILLION) 50
FIGURE 14 ANTI-SNORING DEVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 50
FIGURE 15 ANTI-SNORING DEVICES MARKET, BY REGION, 2024 VS. 2029 (USD MILLION) 51
FIGURE 16 INCREASING INCIDENCE OF SLEEP DISORDERS TO PROPEL MARKET 52
FIGURE 17 ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2024 VS. 2029 (USD MILLION) 52
FIGURE 18 ORAL APPLIANCES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 53
FIGURE 19 ANTI-SNORING DEVICES MARKET, BY GENDER, 2024 VS. 2029 (USD MILLION) 53
FIGURE 20 ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2024 VS. 2029 (USD MILLION) 54
FIGURE 21 ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL,
2024 VS. 2029 (USD MILLION) 54
FIGURE 22 ANTI-SNORING DEVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 55
FIGURE 23 ANTI-SNORING DEVICES MARKET: ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 55
FIGURE 24 ANTI-SNORING DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 56
FIGURE 25 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING & ASSEMBLY PHASES 65
FIGURE 26 SUPPLY CHAIN ANALYSIS: DIRECT DISTRIBUTION IS THE PREFERRED STRATEGY OF PROMINENT COMPANIES 67
FIGURE 27 ANTI-SNORING DEVICES MARKET: ECOSYSTEM ANALYSIS 68
FIGURE 28 ANTI-SNORING DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 69
FIGURE 29 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR ANTI-SNORING DEVICES PATENTS, JANUARY 2014—MARCH 2024 81
FIGURE 30 ANTI-SNORING DEVICES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 83
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ANTI-SNORING DEVICES 83
FIGURE 32 KEY BUYING CRITERIA FOR END USERS OF ANTI-SNORING DEVICES 84
FIGURE 33 ANTI-SNORING DEVICES MARKET: INVESTMENT & FUNDING SCENARIO FOR KEY PLAYERS (2019−2024) 85
FIGURE 34 NORTH AMERICA: ANTI-SNORING DEVICES MARKET SNAPSHOT 149
FIGURE 35 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET SNAPSHOT 186
FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN ANTI-SNORING DEVICES MARKET, 2021−2023 (USD MILLION) 227
FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ANTI-SNORING
DEVICES MARKET (2023) 228
FIGURE 38 RANKING OF KEY PLAYERS IN ANTI-SNORING DEVICES MARKET, 2023 230
FIGURE 39 ANTI-SNORING DEVICES MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2023 231
FIGURE 40 ANTI-SNORING DEVICES MARKET: COMPANY FOOTPRINT 232
FIGURE 41 ANTI-SNORING DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 236
FIGURE 42 EV/EBITDA OF KEY VENDORS 238
FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 238
FIGURE 44 ANTI-SNORING DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 239
FIGURE 45 RESMED: COMPANY SNAPSHOT (2024) 244
FIGURE 46 SOMNOMED: COMPANY SNAPSHOT (2023) 247
FIGURE 47 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY SNAPSHOT (2023) 249
FIGURE 48 VIVOS THERAPEUTICS, INC.: COMPANY SNAPSHOT (2023) 252
MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- ご注文後2営業日以内
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
割引可能なレポートが多数ございます。価格・サンプルについてはお気軽にご相談ください。
最新調査レポート
- 沈降シリカ市場 – 2030年までの世界予測 2025-03-07
- スマートメーター市場 – 2030年までの世界予測 2025-03-07
- 産業用計測市場 – 2030年までの世界予測 2025-03-06
- 精密ろ過膜市場- 2029年までの世界予測 2025-03-06
- グリーンテクノロジーと持続可能性市場 – 2030年までの世界予測 2025-03-06